Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products
Yashoda Hospitals Hyderabad has earned the distinction of becoming the first to introduce BTVA in India
Dupixent peak sales ambition raised to more than €13 billion
This drug-device combination product is a metered-dose inhaler (MDI), which contains both budesonide (a corticosteroid that reduces inflammation) and formoterol (a long-acting bronchodilator that relaxes muscles in the airways to improve breathing)
The recently released WHO guideline on hypertension treatment (2021), recommends that patients with stable blood pressure can be asked to visit clinics at 3-6 month intervals as an important strategy to improve hypertension control
New inhalers would have near-zero Global Warming Potential propellant
The entire integration and transition of the brands is expected to be completed by March 2022
The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad
Arformoterol Tartrate had estimated annual sales of US $ 251 million in the U.S. (IQVIA MAT December 2021)
_256_384.jpg)
India registers 18% of deaths annually due to air pollution while seven million die annually across the world due to air pollution
Subscribe To Our Newsletter & Stay Updated
